Project Grant R21MH134282
- The National Institute of Mental Health awarded the Research Foundation For Mental Hygiene, Inc. (operating as New York State Psychiatric Institute) $1.248 million on August 7, 2026, under the Mental Health Research Grants program (CFDA 93.242) to implement evidence-based early intervention services for young people with untreated psychosis in Mozambique. The project, titled Mental Wellness Coordinated Specialty Care (MWELL-CSC) in Mozambique, develops and deploys a patient-centered digital...
- The National Institute of Mental Health awarded The Rand Corporation $676,820 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to evaluate the decentralization and scale-up of integrated chronic care clinics in Malawi. The award funds a stepped-wedge cluster randomized trial that would permanently transition Malawi's HIV delivery platform—a network of 700 clinics serving over 900,000 clients—into full-time integrated chronic care facilities providing daily...
- The National Institute of Mental Health awarded Brown University $299,660 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate "Chat for Hope," an AI-powered mobile mental health application designed to screen for and address depression, anxiety, and posttraumatic stress symptoms among trauma-exposed adolescents in Ukraine. The project is a collaborative R21/R33 effort between Brown University and the National Academy of...
- The National Institute of Mental Health awarded the University of North Carolina at Chapel Hill $1,454,676 on August 7, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a randomized controlled trial of problem-solving therapy (PST) to improve common mental disorder and HIV care outcomes for people with HIV on antiretroviral therapy in Vietnam. The study tests a task-shifted, non-specialist-delivered mental health intervention designed to address the gap between...
- The National Institute of Mental Health awarded Northwestern University $188,499 under the Mental Health Research Grants program (CFDA 93.242) on July 24, 2026, to adapt digital single-session interventions for delivery by lay providers in rural high schools. The project focuses on addressing barriers to mental health care for adolescents with depression in rural communities, where internalizing problems are more prevalent yet mental health providers and treatment options are scarce. The...
- The National Institute of Mental Health awarded Miresource, Inc. $1.744 million on September 12, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop a longitudinal mental health monitoring platform that generates personalized care guides and treatment referrals. Miresource will integrate software solutions, curate mental health content, and employ artificial intelligence to create personalized guides and automate triage and referral recommendations. The project aims to...
- The National Institute of Mental Health awarded $3.161 million to the University of Texas Health Science Center at Houston on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to study care coordination between hospitals and specialty behavioral health clinics for adults with serious mental illness. The research uses Medicaid administrative claims from multiple states and a quasi-experimental approach to assess whether implementation of the Certified Community...
- The National Institute of Mental Health awarded the University of California, San Diego $2.115 million on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate a mobile health system delivering just-in-time adaptive interventions based on dialectical behavior therapy principles for young adults with comorbid major depressive disorder, social anxiety disorder, generalized anxiety disorder, and related anxiety conditions. The UNDERSTAND project...
- The National Institute of Mental Health awarded Duke University $391,032 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to adapt a telehealth intervention for suicide prevention among patients with alcohol use disorder in Tanzania. The recipient will develop IDEAS-AUD, a telehealth intervention adapted from the evidence-based motivational interviewing intervention MI-SAFECOPE. The intervention addresses suicide risk through a four-pillared approach: reducing...
- The National Institute of Mental Health awarded the University of Georgia Research Foundation, Inc. $415,250 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to assess mental health needs and service access barriers among socially disconnected young adults aged 18–25 in rural areas of the Southern United States. The project leverages geosocial network applications to engage young adults not currently receiving outpatient mental health care and employs ecological...
The National Institute of Mental Health awarded the University of Texas at Austin $171,793 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and test an interactive mobile health chatbot (IPC Trainer) designed to improve the cost-effectiveness and quality of interpersonal counseling delivery by non-specialists treating common mental disorders in community settings in Mozambique. The project addresses two persistent challenges in task-shifted mental health care delivery in low-resource settings: scalable, cost-effective certification of non-specialized providers and maintenance of high-quality care post-certification. The research team has already trained over 300 non-specialists to deliver interpersonal counseling and developed a trilingual mobile health app to support delivery. The chatbot will enhance both the fidelity and quality of interpersonal counseling for depression, anxiety, and post-traumatic stress disorder delivered by non-mental health professionals in community settings. The award supports a two-year R21 exploratory phase running through August 31, 2028, with place of performance in New York, New York. The project operates within Mozambique's national scale-up of task-shared care in partnership with the Ministry of Health, leveraging the existing treatment framework and provider network already established by the research team. The R21 phase focuses on developing and implementing the chatbot using user-centered design principles to ensure feasibility and acceptability among the non-specialist provider workforce.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $47.0k | 8/31/26 | ||
| Not listed | $124.8k | 8/20/26 |